Thai researchers believe they have a cheaper COVID vaccine

The video discusses the development of a new mRNA vaccine in Thailand, which is a novel approach that has not been approved for public use before. The vaccine contains a snippet of the coronavirus's genetic code and is being tested on monkeys to ensure safety before human trials. The process usually takes years, but the urgency of COVID-19 has accelerated development. Ethical concerns about animal testing are addressed, emphasizing the necessity due to the virus's similarity to humans. If successful, this vaccine could offer a cheaper and quicker solution for poorer countries, potentially available in Thailand and other Asian nations by next year.

What is unique about the mRNA vaccine being developed in Thailand?

• It is the first vaccine to use live viruses.

• It contains a snippet of the coronavirus's genetic code.

• It is the first vaccine to be developed in Thailand.

• It uses a completely new type of protein.

Why are monkeys chosen for testing the mRNA vaccine?

• They are the only animals available for testing.

• They are immune to the coronavirus.

• They have a similar immune response to humans.

• They are cheaper to test on than other animals.

What is a major concern of campaigners regarding animal testing?

• It is too expensive.

• It is not necessary or reliable.

• It takes too long to get results.

• It uses too many animals.

How is COVID-19 transforming vaccine development?

• By making it slower and more expensive.

• By eliminating the need for human trials.

• By speeding up the process and reducing costs.

• By requiring more animal testing.

What potential benefit does the mRNA vaccine offer to poorer countries?

• It is a cheaper and quicker alternative.

• It can be produced using local plants.

• It can be developed without any testing.

• It requires no regulatory approval.